2Levy JB.New aspects in the management of ANCA positive vasculitis.Nephrol Dial Transplant,2001,16:1314-1317.
3Jayne DR,Rasmussen N.Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis:initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.Mayo Clin Proc,1997,72(8):737-747.
4Klemmer PJ,Chalermskulrat W,Reif MS,et al.Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis.Am J Kidney Dis,2003,42:1149-1153.
5de Groot K,Adu D,Savage CO.The value of pulse cyclophosphamide in ANCA associated vasculitis:Meta analysis and critical review.Nephrol Dial Transplant,2001,16:2018-2027.
6Joy MS,Hogan SL,Jennette JC,et al.A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis.Nephrol Dial Transplant,2005,20 (12):2725-2732.
7Specks U,Fervenza FC,McDonald TJ,et al.Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy.Arthritis Rheum,2001,44:2836-2840.
8Keogh KA,Wylam ME,Stone JH,et al.Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.Arthritis Rheum,2005,52(1):262-268.
9Eriksson P.Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.J Intern Med,2005,257 (6):540-548.
10Birck R,Warnatz K,Lorenz HM,et al.15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis:A sixmonth open-label trial to evaluate safety and efficacy.JAm Soc Nephrol,2003,14:440-447.
